Our results demonstrated the significantly increased eIF4E expression in glioma cells (Figure 2B), which is consistent with previous results by many other laboratories which showed that eIF4E is overexpressed in many cancers as well as in astrocytic tumours [21–23]. This evidence concerns the gene EIF4E and central nervous system cancer.